Bliss' and Loewe's additive and synergistic effects in Plasmodium falciparum growth inhibition by AMA1-RON2L, RH5, RIPR and CyRPA antibody combinations.

Scientific Reports
Yvonne AzasiKazutoyo Miura

Abstract

Plasmodium invasion of red blood cells involves malaria proteins, such as reticulocyte-binding protein homolog 5 (RH5), RH5 interacting protein (RIPR), cysteine-rich protective antigen (CyRPA), apical membrane antigen 1 (AMA1) and rhoptry neck protein 2 (RON2), all of which are blood-stage malaria vaccine candidates. So far, vaccines containing AMA1 alone have been unsuccessful in clinical trials. However, immunization with AMA1 bound with RON2L (AMA1-RON2L) induces better protection against P. falciparum malaria in Aotus monkeys. We therefore sought to determine whether combinations of RH5, RIPR, CyRPA and AMA1-RON2L antibodies improve their biological activities and sought to develop a robust method for determination of synergy or additivity in antibody combinations. Rabbit antibodies against AMA1-RON2L, RH5, RIPR or CyRPA were tested either alone or in combinations in P. falciparum growth inhibition assay to determine Bliss' and Loewe's additivities. The AMA1-RON2L/RH5 combination consistently demonstrated an additive effect while the CyRPA/RIPR combination showed a modest synergistic effect with Hewlett's [Formula: see text] Additionally, we provide a publicly-available, online tool to aid researchers in analyzing and plann...Continue Reading

References

Dec 8, 2004·International Journal for Parasitology·Deepak GaurLouis H Miller
Aug 25, 2011·Molecular Therapy : the Journal of the American Society of Gene Therapy·Susanne H SheehySimon J Draper
Sep 16, 2011·The New England Journal of Medicine·Mahamadou A TheraChristopher V Plowe
Sep 16, 2011·The New England Journal of Medicine·Sodiomon B SirimaPierre Druilhe
Apr 18, 2012·Human Vaccines & Immunotherapeutics·Christopher J A DuncanRuth D Ellis
Jun 25, 2014·Proceedings of the National Academy of Sciences of the United States of America·Prakash SrinivasanLouis H Miller
Jan 15, 2015·Proceedings of the National Academy of Sciences of the United States of America·K Sony ReddyDeepak Gaur
May 11, 2016·Philosophical Transactions of the Royal Society of London. Series B, Biological Sciences·Desiree Y BaederRoland R Regoes
Aug 12, 2017·Cell Host & Microbe·Alan F CowmanManoj T Duraisingh
Aug 15, 2017·NPJ Vaccines·Prakash SrinivasanLouis H Miller
Oct 29, 2017·Proceedings of the National Academy of Sciences of the United States of America·Leyla Y BustamanteJulian C Rayner
Dec 14, 2018·Nature·Wilson WongAlan F Cowman
Jun 20, 2019·Frontiers in Immunology·Joseph J IllingworthSimon J Draper

❮ Previous
Next ❯

Methods Mentioned

BETA
ELISA

Software Mentioned

R package
R

Related Concepts

Related Feeds

Antimalarial Agents (ASM)

Antimalarial agents, also known as antimalarials, are designed to prevent or cure malaria. Discover the latest research on antimalarial agents here.

Antimalarial Agents

Antimalarial agents, also known as antimalarials, are designed to prevent or cure malaria. Discover the latest research on antimalarial agents here.